Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Par-4-dependent apoptosis by the dietary compound withaferin A in prostate cancer cells.

Srinivasan S, Ranga RS, Burikhanov R, Han SS, Chendil D.

Cancer Res. 2007 Jan 1;67(1):246-53. Epub 2006 Dec 21.

2.

A herbal medicine for the treatment of lung cancer.

Ranga RS, Sowmyalakshmi S, Burikhanov R, Akbarsha MA, Chendil D.

Mol Cell Biochem. 2005 Dec;280(1-2):125-33.

PMID:
16311913
3.

Investigation on Semecarpus Lehyam--a Siddha medicine for breast cancer.

Sowmyalakshmi S, Nur-E-Alam M, Akbarsha MA, Thirugnanam S, Rohr J, Chendil D.

Planta. 2005 Apr;220(6):910-8. Epub 2004 Oct 28.

PMID:
15517350
4.

Rasagenthi lehyam (RL) a novel complementary and alternative medicine for prostate cancer.

Ranga RS, Girija R, Nur-e-Alam M, Sathishkumar S, Akbarsha MA, Thirugnanam S, Rohr J, Ahmed MM, Chendil D.

Cancer Chemother Pharmacol. 2004 Jul;54(1):7-15. Epub 2004 Mar 24.

PMID:
15042313
5.

Curcumin confers radiosensitizing effect in prostate cancer cell line PC-3.

Chendil D, Ranga RS, Meigooni D, Sathishkumar S, Ahmed MM.

Oncogene. 2004 Feb 26;23(8):1599-607.

PMID:
14985701
6.

Uterine sarcomas express KIT protein but lack mutation(s) in exon 11 or 17 of c-KIT.

Rushing RS, Shajahan S, Chendil D, Wilder JL, Pulliam J, Lee EY, Ueland FR, van Nagell JR, Ahmed MM, Lele SM.

Gynecol Oncol. 2003 Oct;91(1):9-14.

PMID:
14529657
8.

Low-dose fractionated radiation potentiates the effects of Paclitaxel in wild-type and mutant p53 head and neck tumor cell lines.

Dey S, Spring PM, Arnold S, Valentino J, Chendil D, Regine WF, Mohiuddin M, Ahmed MM.

Clin Cancer Res. 2003 Apr;9(4):1557-65.

9.

Didox (a novel ribonucleotide reductase inhibitor) overcomes Bcl-2 mediated radiation resistance in prostate cancer cell line PC-3.

Inayat MS, Chendil D, Mohiuddin M, Elford HL, Gallicchio VS, Ahmed MM.

Cancer Biol Ther. 2002 Sep-Oct;1(5):539-45.

PMID:
12496485
10.

Farnesyltransferase inhibitor (L-744,832) restores TGF-beta type II receptor expression and enhances radiation sensitivity in K-ras mutant pancreatic cancer cell line MIA PaCa-2.

Alcock RA, Dey S, Chendil D, Inayat MS, Mohiuddin M, Hartman G, Chatfield LK, Gallicchio VS, Ahmed MM.

Oncogene. 2002 Nov 7;21(51):7883-90.

11.

Suppression of retrovirus-induced immunodeficiency disease (murine AIDS) by trimidox and didox: novel ribonucleotide reductase inhibitors with less bone marrow toxicity than hydroxyurea.

Mayhew CN, Mampuru LJ, Chendil D, Ahmed MM, Phillips JD, Greenberg RN, Elford HL, Gallicchio VS.

Antiviral Res. 2002 Nov;56(2):167-81.

PMID:
12367722
12.
13.

Increased expression of PSA mRNA during brachytherapy in peripheral blood of patients with prostate cancer.

Siddiqua A, Chendil D, Rowland R, Meigooni AS, Kudrimoti M, Mohiuddin M, Ahmed MM.

Urology. 2002 Aug;60(2):270-5.

PMID:
12137825
14.

Influence of p53 status on radiation and 5-flourouracil synergy in pancreatic cancer cells.

Mohiuddin M, Chendil D, Dey S, Alcock RA, Regine W, Mohiuddin M, Ahmed MM.

Anticancer Res. 2002 Mar-Apr;22(2A):825-30.

PMID:
12014658
15.

Restoration of transforming growth factor-beta signaling enhances radiosensitivity by altering the Bcl-2/Bax ratio in the p53 mutant pancreatic cancer cell line MIA PaCa-2.

Ahmed MM, Alcock RA, Chendil D, Dey S, Das A, Venkatasubbarao K, Mohiuddin M, Sun L, Strodel WE, Freeman JW.

J Biol Chem. 2002 Jan 18;277(3):2234-46. Epub 2001 Nov 1.

16.

Early growth response-1 gene: potential radiation response gene marker in prostate cancer.

Ahmed MM, Chendil D, Lele S, Venkatasubbarao K, Dey S, Ritter M, Rowland RG, Mohiuddin M.

Am J Clin Oncol. 2001 Oct;24(5):500-5.

PMID:
11586104
17.

Low dose fractionated radiation enhances the radiosensitization effect of paclitaxel in colorectal tumor cells with mutant p53.

Chendil D, Oakes R, Alcock RA, Patel N, Mayhew C, Mohiuddin M, Gallicchio VS, Ahmed MM.

Cancer. 2000 Nov 1;89(9):1893-900.

PMID:
11064345
18.

Ionizing radiation down-regulates p53 protein in primary Egr-1-/- mouse embryonic fibroblast cells causing enhanced resistance to apoptosis.

Das A, Chendil D, Dey S, Mohiuddin M, Mohiuddin M, Milbrandt J, Rangnekar VM, Ahmed MM.

J Biol Chem. 2001 Feb 2;276(5):3279-86. Epub 2000 Oct 16.

19.

Cytogenetic and molecular genetic studies on Indian patients with chronic lymphocytic leukemia.

Kumaravel TS, Chendil D, Arif M, Asou H, Bharadwaj TP, Sethuraman S, Susheela M, Raina V, Bhargava M, Pant GS, Tanaka K, Murthy PB, Kamada N.

Int J Hematol. 1996 Jul;64(1):31-7.

PMID:
8757965

Supplemental Content

Loading ...
Support Center